JP2022553056A5 - - Google Patents
Info
- Publication number
- JP2022553056A5 JP2022553056A5 JP2022523585A JP2022523585A JP2022553056A5 JP 2022553056 A5 JP2022553056 A5 JP 2022553056A5 JP 2022523585 A JP2022523585 A JP 2022523585A JP 2022523585 A JP2022523585 A JP 2022523585A JP 2022553056 A5 JP2022553056 A5 JP 2022553056A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- group
- sirna
- formula
- sirna28
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962925659P | 2019-10-24 | 2019-10-24 | |
| US62/925,659 | 2019-10-24 | ||
| PCT/US2020/057185 WO2021081420A2 (en) | 2019-10-24 | 2020-10-23 | Conjugates and methods for treating acromegaly |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553056A JP2022553056A (ja) | 2022-12-21 |
| JP2022553056A5 true JP2022553056A5 (https=) | 2023-10-27 |
| JP7668032B2 JP7668032B2 (ja) | 2025-04-24 |
Family
ID=75620892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523585A Active JP7668032B2 (ja) | 2019-10-24 | 2020-10-23 | 先端巨大症を処置するためのコンジュゲート及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220288214A1 (https=) |
| EP (1) | EP4048801A4 (https=) |
| JP (1) | JP7668032B2 (https=) |
| CN (1) | CN114616339A (https=) |
| AU (1) | AU2020371736A1 (https=) |
| BR (1) | BR112022007725A2 (https=) |
| CA (1) | CA3158917A1 (https=) |
| IL (1) | IL292391A (https=) |
| WO (1) | WO2021081420A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3020585A1 (en) * | 2016-04-11 | 2017-10-19 | Arbutus Biopharma Corporation | Targeted nucleic acid conjugate compositions |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2322651A1 (en) * | 2004-05-14 | 2011-05-18 | Rosetta Genomics Ltd | MicroRNAs and uses thereof |
| CA2917229A1 (en) * | 2013-07-02 | 2015-01-08 | Isis Pharmaceuticals, Inc. | Modulators of growth hormone receptor |
| BR112016022742B1 (pt) * | 2014-05-01 | 2022-06-14 | Ionis Pharmaceuticals, Inc | Composto químico, composição compreendendo o composto e uso dos mesmos |
| WO2015179693A1 (en) * | 2014-05-22 | 2015-11-26 | Isis Pharmaceuticals, Inc. | Conjugated antisense compounds and their use |
| EP3151839A4 (en) * | 2014-06-06 | 2018-02-28 | Ionis Pharmaceuticals, Inc. | Compositions and methods for enhanced intestinal absorption of conjugated oligomeric compounds |
| EP3228326A1 (en) | 2016-04-05 | 2017-10-11 | Silence Therapeutics GmbH | Nucleic acid linked to a trivalent glycoconjugate |
| DK3607069T3 (da) | 2017-04-05 | 2022-11-21 | Silence Therapeutics Gmbh | Produkter og sammensætninger |
| WO2018185253A1 (en) * | 2017-04-05 | 2018-10-11 | Silence Therapeutics Gmbh | Ligand modified double-stranded nucleic acids |
| JP7406793B2 (ja) * | 2017-06-23 | 2023-12-28 | ユニバーシティー オブ マサチューセッツ | ２テイル自己デリバリー型ｓｉＲＮＡおよび関連方法 |
| EP3775209A1 (en) * | 2018-04-05 | 2021-02-17 | Silence Therapeutics GmbH | Sirnas with at least two ligands at different ends |
-
2020
- 2020-10-23 CA CA3158917A patent/CA3158917A1/en active Pending
- 2020-10-23 WO PCT/US2020/057185 patent/WO2021081420A2/en not_active Ceased
- 2020-10-23 BR BR112022007725A patent/BR112022007725A2/pt unknown
- 2020-10-23 IL IL292391A patent/IL292391A/en unknown
- 2020-10-23 US US17/770,504 patent/US20220288214A1/en not_active Abandoned
- 2020-10-23 JP JP2022523585A patent/JP7668032B2/ja active Active
- 2020-10-23 AU AU2020371736A patent/AU2020371736A1/en not_active Abandoned
- 2020-10-23 CN CN202080075748.1A patent/CN114616339A/zh active Pending
- 2020-10-23 EP EP20879819.9A patent/EP4048801A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023505434A5 (https=) | ||
| JP2020100637A (ja) | Ｔｌｒ７作動薬およびｈｂｖカプシド集合阻害剤を用いた併用処置 | |
| JP2022081661A5 (https=) | ||
| JP2020511512A (ja) | 腫瘍の治療または予防のための併用療法 | |
| JP2011517683A5 (https=) | ||
| RU2010126105A (ru) | Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства | |
| JP2022522486A5 (https=) | ||
| JP2020532562A5 (https=) | ||
| WO2019046287A1 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEPATITIS B | |
| JP2022553056A5 (https=) | ||
| US20100222376A1 (en) | Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders | |
| JP2025503521A5 (https=) | ||
| JP2024504002A (ja) | がんを処置する方法 | |
| JP2024500874A (ja) | がんを処置する方法 | |
| JP2025502383A5 (https=) | ||
| JP2021527650A5 (https=) | ||
| CN110461329A (zh) | 治疗血癌的PPARγ激动剂 | |
| JP2023548295A5 (https=) | ||
| JP2021523881A5 (https=) | ||
| JP2021503486A5 (https=) | ||
| JP2026503618A5 (https=) | ||
| JP2022554330A5 (https=) | ||
| JP2022510374A5 (https=) | ||
| US11554111B2 (en) | Sphingosine pathway modulating compounds for the treatment of coronavirus infection | |
| JP2003527414A (ja) | Ｃ型肝炎を治療するための薬剤 |